Not all patients are able to reap the benefits of groundbreaking new therapeutics. The industry must do more.

Personalized medicine, digital therapeutics, and GLP-1s; experts tell us what areas are hot in pharma’s future.

Alcami experts discuss what’s needed to accelerate drug development.

How next-generation drug delivery and advanced automation are set to transform pharma’s future.

How will digitalization and automation redefine pharma manufacturing in the next decade?

Takeda experts explore the potential of AI-driven drug discovery and the importance of including diverse patient voices in trial design.

Colleen Dixon and Mary Glotzbach discuss key areas for improvement, including automation, eco-friendly practices, and patient-centric delivery methods

Regeneron’s Gary Herman discusses the future of genetic medicines and the role of new delivery systems.

How AI-driven process optimization could lower costs and improve success rates in drug development.